It has been confirmed that translational defects in mitochondrial and nuclear DNA, typically seen in mitochondrial diseases involving skeletal muscle, lead to increased FGF21/GDF15 levels. The gene discussed is GDF15; the disease is inborn mitochondrial metabolism disorder.